Sunshine Biopharma Stock Technical Analysis
| SBFM Stock | USD 2.13 0.01 0.47% |
As of the 26th of March, Sunshine Biopharma has the Coefficient Of Variation of (1,600), variance of 20.15, and Risk Adjusted Performance of (0.04). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sunshine Biopharma, as well as the relationship between them. Please validate Sunshine Biopharma market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Sunshine Biopharma is priced more or less accurately, providing market reflects its prevalent price of 2.13 per share. Please also confirm Sunshine Biopharma jensen alpha, which is currently at (0.30) to double-check the company can sustain itself at a future point.
Sunshine Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sunshine, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SunshineSunshine |
Sunshine Biopharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 300.0 | Strong Buy | 1 | Odds |
Most Sunshine analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sunshine stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sunshine Biopharma, talking to its executives and customers, or listening to Sunshine conference calls.
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sunshine Biopharma Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sunshine Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sunshine Biopharma Trend Analysis
Use this graph to draw trend lines for Sunshine Biopharma. You can use it to identify possible trend reversals for Sunshine Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sunshine Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sunshine Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sunshine Biopharma applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Sunshine Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 13.77, which is the sum of squared deviations for the predicted Sunshine Biopharma price change compared to its average price change.About Sunshine Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sunshine Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sunshine Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sunshine Biopharma price pattern first instead of the macroeconomic environment surrounding Sunshine Biopharma. By analyzing Sunshine Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sunshine Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sunshine Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Sunshine Biopharma March 26, 2025 Technical Indicators
Most technical analysis of Sunshine help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sunshine from various momentum indicators to cycle indicators. When you analyze Sunshine charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.14) | |||
| Mean Deviation | 3.24 | |||
| Coefficient Of Variation | (1,600) | |||
| Standard Deviation | 4.49 | |||
| Variance | 20.15 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.15) | |||
| Maximum Drawdown | 24.99 | |||
| Value At Risk | (7.36) | |||
| Potential Upside | 7.91 | |||
| Skewness | (0.12) | |||
| Kurtosis | 1.3 |
Sunshine Biopharma March 26, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sunshine stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,156 | ||
| Daily Balance Of Power | 0.07 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.18 | ||
| Day Typical Price | 2.16 | ||
| Price Action Indicator | (0.05) |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (127.90) | Revenue Per Share | Quarterly Revenue Growth 0.416 | Return On Assets | Return On Equity |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.